BCV
AGN

Banque Cantonale Vaudoise’s Allergan plc AGN Stock Holding History

Banque Cantonale Vaudoise’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,697
Closed -$301K – 982
2020
Q1 		$301K Hold
1,697
– – 0.03% 515
2019
Q4 		$325K Buy
+1,697
New +$306K 0.02% 601

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Banque Cantonale Vaudoise's AGN Position: Q2 2020 in Review

Banque Cantonale Vaudoise sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,697 shares — an estimated $301K sold.

Banque Cantonale Vaudoise first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $325K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Banque Cantonale Vaudoise reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 1,697 Allergan plc shares in Q2 2020, an estimated $301K.
  • Banque Cantonale Vaudoise first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Banque Cantonale Vaudoise's Allergan plc position peaked at $325K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2020, filed 22 Jul 2020.